HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-137 Cr | ₹-174 Cr | ₹-292 Cr | ₹-284 Cr | ₹-156 Cr |
What is the latest Cash Flow from Investing Activities ratio of HIKAL ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-137 Cr |
| Mar2024 | ₹-174 Cr |
| Mar2023 | ₹-292 Cr |
| Mar2022 | ₹-284 Cr |
| Mar2021 | ₹-156 Cr |
How is Cash Flow from Investing Activities of HIKAL Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-137 Cr | Negative | |
| Mar2024 | ₹-174 Cr | Negative | |
| Mar2023 | ₹-292 Cr | Negative | |
| Mar2022 | ₹-284 Cr | Negative | |
| Mar2021 | ₹-156 Cr | - | |
Compare Cash Flow from Investing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,269.3 Cr | -8.9% | -5.9% | -46.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -8.9% |
-5.9% |
-46.3% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses